Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
Search Medicine Database
Home
Medicines
Active Ingredients
Companies
DHPC
Advanced Search
Side Effect Reporting
Login
menu
Home
Active Ingredients
Eptinezumab
Eptinezumab
Medicine
Status
Monitoring
SPC
PIL
XPIL
Legal Category
Active Ingredient(s)
Company
Vyepti concentrate for solution for infusion 100 mg (300 mg not marketed)
No Recent Update
SPC
PIL
No
A
Eptinezumab
Lundbeck (Ireland) Limited
Cookies